XML 200 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
[1]
Ordinary Shares
Additional Paid-In Capital
Treasury Stock
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
[1]
Beginning balance (in shares) at Dec. 31, 2018     49,323,000          
Beginning balance at Dec. 31, 2018 $ 1,500,448 [1]   $ 76,144 $ 1,705,111 $ (1,462) $ (24,476) $ (254,869) [1]  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation plans (in shares)     88,000          
Stock-based compensation plans 30,071 [1]   $ 113 29,759 199      
Net loss [1] (157,639) [2],[3],[4]           (157,639)  
Other comprehensive income (loss) 5,084 [1],[3]         5,084    
Ending balance (in shares) at Dec. 31, 2019     49,411,000          
Ending balance at Dec. 31, 2019 1,377,964 [1] $ (639) $ 76,257 1,734,870 (1,263) (19,392) (412,508) [1] $ (639)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation plans (in shares)     109,000          
Stock-based compensation plans 33,558 [1]   $ 140 33,189 229      
Cancellation of shares (in shares)     (73,000)          
Cancellation of shares     $ (97) 97        
Net loss [1] (348,819) [2],[3],[4]           (348,819)  
Other comprehensive income (loss) $ 47,201 [1],[3]         47,201    
Ending balance (in shares) at Dec. 31, 2020 49,447,473   49,447,000          
Ending balance at Dec. 31, 2020 $ 1,109,265 [1],[5]   $ 76,300 1,768,156 (1,034) 27,809 (761,966) [1]  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issuance (in shares)     4,182,000          
Issuance of shares 322,541   $ 5,808 316,733        
Stock-based compensation plans (in shares)     133,000          
Stock-based compensation plans 33,643   $ 187 33,072 384      
Net loss (135,818)           (135,818)  
Other comprehensive income (loss) $ (34,986)         (34,986)    
Ending balance (in shares) at Dec. 31, 2021 53,761,510   53,762,000          
Ending balance at Dec. 31, 2021 $ 1,294,645   $ 82,295 $ 2,117,961 $ (650) $ (7,177) $ (897,784)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] Accounting Standards Update 2016-13 [Member]              
[1] Accumulated deficit and total stockholders’ equity as of December 31, 2020, 2019 and 2018, and net loss for the years ended December 31, 2020 and 2019 have been revised. For further details refer to “Note 1. Nature of Operations.”
[2] The consolidated statements of cash flows for the years ended December 31, 2020 and 2019 have been revised. For further details refer to “Note 1. Nature of Operations.”
[3] The consolidated statements of comprehensive income (loss) for the years ended December 31, 2020 and 2019 have been revised. For further details refer to “Note 1. Nature of Operations.”
[4] The consolidated statements of income (loss) for the years ended December 31, 2020 and 2019 have been revised. For further details refer to “Note 1. Nature of Operations.”
[5] The consolidated balance sheet as of December 31, 2020 has been revised. For further details refer to “Note 1. Nature of Operations.”